维京治疗 VKTX
$26.84 +$1.05 (+4.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $26.80 -0.15%
开盘$25.81
昨收$25.79
当日区间$25.55 – $27.03
成交量2.67M
市值$3.42B
市盈率（TTM）–
股息率–
财报
财报日平均波动±8.0%近16次财报
收涨次数10 / 1663% 的概率
最佳反应+28.3%
最差反应-9.4%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | After Market | ±6.8% | +5.91% | 符合区间 |
| 2026/Q2 | 29 Jul 2026 | After Market | ±9.4% | -0.96% | 符合区间 |
| 2026/Q1 | 29 Apr 2026 | After Market | ±7.3% | -0.48% | 符合区间 |
| 2025/Q4 | 11 Feb 2026 | After Market | ±10.9% | +6.80% | 符合区间 |
| 2025/Q3 | 22 Oct 2025 | After Market | ±7.9% | +7.96% | 超出定价预期 |
| 2025/Q2 | 23 Jul 2025 | After Market | ±11.9% | +0.30% | 符合区间 |
| 2025/Q1 | 23 Apr 2025 | After Market | ±10.2% | -0.50% | 符合区间 |
| 2024/Q4 | 5 Feb 2025 | After Market | ±11.7% | -6.09% | 符合区间 |
| 2024/Q3 | 23 Oct 2024 | After Market | ±9.9% | +21.25% | 超出定价预期 |
| 2024/Q2 | 24 Jul 2024 | After Market | ±15.9% | +28.31% | 超出定价预期 |
| 2024/Q1 | 24 Apr 2024 | After Market | ±9.8% | +5.82% | 符合区间 |
| 2023/Q4 | 7 Feb 2024 | After Market | ±20.2% | +18.01% | 符合区间 |
| 2023/Q3 | 25 Oct 2023 | After Market | ±8.5% | -9.42% | 超出定价预期 |
| 2023/Q2 | 26 Jul 2023 | After Market | ±8.2% | -3.99% | 符合区间 |
| 2023/Q1 | 26 Apr 2023 | After Market | – | +0.31% | – |
| 2022/Q4 | 8 Feb 2023 | After Market | ±18.5% | +11.72% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q3, ended Sep 2026
营收$0.00
营业利润-$187.11M-89.8% YoY
净利润-$183.19M-101.8% YoY
摊薄每股收益-$1.55-91.4% YoY
自由现金流-$138.19M-47.0% YoY
经营现金流-$138.19M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
净资产收益率-96.4%
资产收益率-73.1%
投入资本回报率-83.3%
流动比率7.27
负债/资产比率39.8%
现金及投资$959.81M
总负债$254.67M
净现金（净负债）$705.14M
暂无评论——快来第一个聊聊 VKTX。
登录后参与讨论。